[1] 黄海福.犀角地黄汤治疗卡培他滨化疗引起的手足综合征的临床
研究[J].江西中医药,2016,47(8):52-53.
[2] Kruger S, Boeck S, Heinemann V, et al. Impact of handfoot
skin reaction on treatment outcome in patients receiving
capecitabine plus erlotinib for advanced pancreatic cancer:
a subgroup analysis from AIO- PK0104 [J]. Acta Oncol,
2015,54(7):993-1000.
[3] Blum JL, Jones SE, Buzdar AU, et al. Multicenter phase
Ⅱ study of capecitabine in paclitaxel- refractory metastatic
breast cancer [J]. J ClinOncol, 1999,17(2):485-493.
[4] 张杏华,潘珊,户坤,等. 光子治疗仪联合医比克治疗卡培他滨所
致手足综合征的疗效观察[J].临床医学工程,2017,24(12):1654.
[5] Jeong YP. Differential diagnosis between hand- foot syndrome
and gout in colorectal cancer with capecitabine:a
case study and review of the literature [J]. Asian Oncol-
Nurs, 2014,14(1):1-6.
[6] 闻飞飞,赵美随. 超声药物透入疗法防治卡培他滨相关性手足综
合征35例[J].中医临床研究,2015,7(18):142-144.
[7] Toyama T, Yoshimura A, Hayashi T, et al. A randomized
phase Ⅱ study evaluating pyridoxine for the prevention
of hand- foot syndrome associated with capecitabine
therapy for advanced or metastatic breast cancer [J]. Breast
cancer, 2018,14(5):245-261.
[8] BraikT, Yim B, Evans AT, et al . Randomized trial of vitamin
B6 for preventing hand- foot syndrome from capecitabinechemotherapy
[J]. J Community Support Oncol, 2014,
12(2):65-69.